BioRestorative Therapies (BRTX) Other Working Capital Changes (2021 - 2025)
BioRestorative Therapies' (BRTX) quarterly Other Working Capital Changes came in at $150000.0 in Q1 2025, up 486.79% YoY from $25562.9 in Q1 2024, and up 453.66% on a QoQ basis from -$42414.0 in Q4 2024.
BioRestorative Therapies (BRTX) Other Working Capital Changes (2021 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 5 years of Other Working Capital Changes data on file, last reported at $150000.0 in Q1 2025.
- Quarterly Other Working Capital Changes rose 486.79% year-over-year to $150000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $26464.0 (up 118.27% YoY) and the FY2024 annual result came in at -$162317.0, down 16.5% from the prior year.
- Other Working Capital Changes rose to $150000.0 in Q1 2025, from -$42414.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $404225.0 in Q4 2021 to a low of -$165787.0 in Q2 2022.
- A 5-year average of $3223.2 and a median of -$16988.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 184.36% — and 2025, when it jumped 486.79%.
- Tracing BRTX's Other Working Capital Changes over 5 years: stood at -$26441.0 in 2021, then plunged by 184.36% to -$75187.0 in 2022, then soared by 51.58% to -$36407.0 in 2023, then decreased by 16.5% to -$42414.0 in 2024, then soared by 453.66% to $150000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $150000.0 (Q1 2025), -$42414.0 (Q4 2024), and -$41166.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | -42,414.00 |
| Dec 31, 2024 | -42,414.00 |
| Dec 31, 2024 | -42,414.00 |
| Sep 30, 2024 | -41,166.00 |
| Sep 30, 2024 | -41,166.00 |
| Sep 30, 2024 | -41,166.00 |
| Jun 30, 2024 | -39,956.00 |
| Jun 30, 2024 | -39,956.00 |
| Jun 30, 2024 | -39,956.00 |
| Mar 31, 2024 | -38,781.00 |
| Mar 31, 2024 | -38,781.00 |
| Mar 31, 2024 | -38,781.00 |
| Dec 31, 2023 | -36,407.00 |
| Dec 31, 2023 | -36,407.00 |
| Dec 31, 2023 | -36,407.00 |
| Sep 30, 2023 | -35,336.00 |
| Sep 30, 2023 | -35,336.00 |